Total planned funding: $23,546,626
Allocations
Countries/Regions
Central Asia Region | $23,546,626 |
Organizational Types
Own Agency | $23,546,626 |
Program Areas
Management and Operations | $18,061,739 |
Prevention | $2,213,174 |
Governance and Systems | $1,681,640 |
Care | $672,519 |
Testing | $540,343 |
Treatment | $377,211 |
Budget Codes
HVMS: Management and Operations | $18,061,739 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,505,156 |
HLAB: Laboratory Infrastructure | $759,030 |
HVSI: Strategic Information | $640,590 |
HBHC: Care: Adult Care and Support | $592,743 |
HVCT: Testing: HIV Testing and Counseling | $540,343 |
HVOP: Sexual Prevention: Other Sexual Prevention | $419,483 |
HTXS: Treatment: Adult Treatment | $377,211 |
OHSS: Health Systems Strengthening | $282,020 |
HMBL: Biomedical Prevention: Blood Safety | $148,027 |
HMIN: Biomedical Prevention: Injection Safety | $140,508 |
HVTB: Care: TB/HIV | $79,776 |
Top Partner Programs
USG Aggregated Agencies:
$12,407,263
Countries/Regions
Central Asia Region
2010 | $3,180,975 |
2011 | $5,099,999 |
2016 | $4,126,289 |
U.S. Centers for Disease Control and Prevention:
$6,221,704
Countries/Regions
Central Asia Region
2013 | $3,238,500 |
2014 | $2,983,204 |
U.S. Agency for International Development:
$4,917,659
Countries/Regions
Central Asia Region
2013 | $2,538,500 |
2014 | $2,379,159 |